insights_auto
Bakit tumaas ang PHIO 2.91%?
Tingnan ang Higit pang Detalyechevron_right
PHIO:NASDAQ
Phio Pharmaceuticals Corp
$0.92
arrow_upward
+2.91%(+0.026) 1D
Okt 21, 11:11:48 AM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa PHIO...
Buksan
$0.91
Mataas
$0.92
Mababa
$0.86
Mkt. cap
10.69M
Avg. na dami
101.47K
Dami
14.14K
Mataas nang 52-wk
$4.19
Mababa nang 52-wk
$0.81
EPS
-$1.39
Beta
0.84
Mga natitirang share
11.62M
Bilang ng mga empleyado
6
Buksan
$0.91
Mataas
$0.92
Mababa
$0.86
Mkt. cap
10.69M
Avg. na dami
101.47K
Dami
14.14K
Mataas nang 52-wk
$4.19
Mababa nang 52-wk
$0.81
EPS
-$1.39
Beta
0.84
Mga natitirang share
11.62M
Bilang ng mga empleyado
6
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Investing.com
·
13 oras ang nakalipas
S&P, Nasdaq open higher as SpaceX, Tesla climb on Musk’s update on possible merger
Bloomberg.com
·
19 oras ang nakalipas
US Futures Slip as Neocloud IPO Elice Flops, SpaceX Results Loom
MarketWatch
·
1 buwan ang nakalipas
Bloom Energy was just named to the S&P 500. These other stocks are joining the index as well.
Reuters
·
1 buwan ang nakalipas
S&P 500 ends down as oil tops $100 per barrel
Profile
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
Tungkol sa Phio Pharmaceuticals Corp